SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Array BioPharma, Inc. (ARRY)

ARRY RSS Feed
Add ARRY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/21/2016 8:06:22 PM - Followers: 47 - Board type: Free - Posts Today: 0
http://www.arraybiopharma.com/

http://finance.yahoo.com/q/ks?s=ARRY

http://investorshub.advfn.com/boards/read_msg.asp?message_id=27628473

http://www.form4oracle.com/company?cik=0001100412&ticker=arry

Array BioPharma, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat debilitating and life-threatening diseases. Its proprietary drug development pipeline primarily focuses on the treatment of cancer and inflammatory disease, and includes clinical candidates that are designed to regulate therapeutically important target proteins. The company's principal products include ARRY-886, which is an MEK inhibitor for cancer, and is in randomized phase II clinical trials in malignant melanoma; ARRY-543, an ErbB-2/EGFR inhibitor, which is in phase I clinical trials; ARRY-162, an MEK inhibitor for inflammation, which is in phase I clinical trials; ARRY-797, a p38 inhibitor; and ARRY-520, a KSP inhibitor. It has partnerships with Amgen, Inc.; AstraZeneca PLC; Genentech, Inc.; ICOS Corporation; InterMune, Inc.; Japan Tobacco, Inc.; Ono Pharmaceutical Co., Ltd.; and Takeda Pharmaceutical Company, Ltd. The company was founded in 1998 and is headquartered in Boulder, Colorado.




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ARRY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ARRY News: Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference 11/22/2016 10:00:00 AM
ARRY News: Biotech Stocks Forge Ahead With Confidence on This Week's Healthy Biotech Rally 11/17/2016 08:45:00 AM
ARRY News: COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress 11/09/2016 11:00:00 AM
ARRY News: Current Report Filing (8-k) 11/09/2016 10:17:46 AM
ARRY News: COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress 11/09/2016 10:00:00 AM
PostSubject
#364   Ok then not much feedback here so I Easymoneyman00 11/21/16 08:06:22 PM
#363   HELLO... echo...echo...echo..? Easymoneyman00 11/21/16 08:05:07 PM
#362   So it seems that REDMILE made bank and XenaLives 11/16/16 09:28:32 AM
#361   I'm new to this board I bought ARRY Easymoneyman00 11/12/16 09:44:13 PM
#360   I'm new to this board I bought ARRY Easymoneyman00 11/12/16 09:43:53 PM
#359   Array Biopharma Updates On COLUMBUS Phase 3 And trendmkr 11/10/16 11:56:37 AM
#358   all right true believers. what i gather sidslids 11/10/16 09:59:50 AM
#357   pins and needles, that is right! you sidslids 11/10/16 09:54:15 AM
#356   my thesis at this part, declares that harvard sidslids 11/09/16 07:23:53 PM
#355   more investor meetings next week. sidslids 11/09/16 03:22:49 PM
#354   i don't recall ever hearing handclaps after the sidslids 11/09/16 02:26:42 PM
#353   well. sidslids 11/09/16 01:39:41 PM
#352   an exuberant beginning of the day, but now sidslids 11/09/16 01:14:46 PM
#351   nov 9th press release available under sec forms 8k sidslids 11/09/16 11:02:57 AM
#350   pps is responding well i must say, sidslids 11/09/16 10:30:17 AM
#349   they have that late breaking abstract thing at sidslids 11/08/16 04:02:05 PM
#348   reminder: wed. nov 9. sidslids 11/08/16 11:18:36 AM
#347   What's nov 9th? MikeBK205 11/07/16 02:42:38 PM
#346   the harvards are saying this is only worth sidslids 11/07/16 12:57:32 PM
#345   it appears as if the princetons haven't got sidslids 11/07/16 12:43:55 PM
#344   oh no, it appears as if i offended sidslids 11/07/16 12:36:28 PM
#343   $6.08 is all right, but the yale-ies are sidslids 11/07/16 12:34:03 PM
#342   dear sids, sidslids 11/07/16 11:54:17 AM
#341   you call that volume? who are you kidding. sidslids 11/07/16 11:52:48 AM
#340   the ask is only $6.04??? come on players. sidslids 11/07/16 11:50:39 AM
#339   reminder: wed. nov 9. sidslids 11/07/16 10:16:36 AM
#338   reminder: wed. nov 9. sidslids 10/29/16 11:07:07 AM
#337   What happens now that the offering ended on MikeBK205 10/23/16 09:37:35 PM
#336   meh.. sidslids 10/21/16 03:45:13 PM
#335   meh. sidslids 10/20/16 04:33:48 PM
#334   meh. sidslids 10/19/16 03:59:55 PM
#333   ARRY bullish 6.795 stocktrademan 10/10/16 05:03:42 PM
#332   any ideas as to how long we have sidslids 10/07/16 10:43:47 AM
#331   Array BioPharma Closes Underwritten Public Offering trendmkr 10/05/16 10:53:13 AM
#329   Looking at getting in this. Is there a PharmD08 10/02/16 06:48:01 PM
#328   form4 dated 9.30.16 sidslids 09/30/16 07:19:54 PM
#327   ARRY 6.55 nice. Time to go up PAC 09/30/16 10:48:03 AM
#326   No doubt some big money is loading. Yesterday matt24d 09/28/16 04:16:34 PM
#325   ARRY 6.3 went long and holding for $8++ PAC 09/28/16 02:03:31 PM
#324   Let's move up now hit the offering price mykoll 09/28/16 11:14:04 AM
#323   I am holding my shares in this one. matt24d 09/28/16 10:37:04 AM
#322   Shorts are pushing hard hold on ! mykoll 09/28/16 10:26:50 AM
#321   Pretty Rare a biotech announces financing and it matt24d 09/28/16 09:38:19 AM
#320   The way it traded it float on Monday matt24d 09/28/16 07:25:32 AM
#319   4 was a total rookie call..no way they MichaelAria 09/28/16 07:19:52 AM
#318   They were priced at 6.25 and that is matt24d 09/28/16 07:10:20 AM
#317   BAKER BROS>>>ORBIMED>>>>SARISSA are among the holders in ARRY...maybe MichaelAria 09/27/16 10:09:05 PM
#316   Yes it held up pretty good I am mykoll 09/27/16 09:51:08 PM
#315   Yeah sure thats it 4 bucks...try 6.50 to MichaelAria 09/27/16 09:38:13 PM
#314   http://www.fool.com/investing/2016/09/27/3-reasons-to-buy-array-biopharma.aspx?s Stockyang 09/27/16 06:55:40 PM
PostSubject